Section 17-1737-93 - Allogenic bone marrow transplant(a) Indications for allogenic bone marrow transplant include:(1) Severe aplastic anemia unresponsive to usual therapy;(2) Acute myelogenous leukemia in first remission;(3) Acute lymphocytic leukemia in second remission; and(4) Chronic leukemia after first year.(b) Conditions and limitations affecting allogenic bone marrow transplant include: (1) Human leukocyte group A (HLA) histocompatible donor shall be available;(2) Patient has no other major systemic disease which would result in poor potential for recovery (such as a heart condition, liver disease, kidney damage, brain lesions, cancer in other organs or lung disease);(3) Patient shall have been properly evaluated by a qualified authority in Hawaii and bone marrow transplant is recommended as a possible curative procedure or if palliative, with reasonable likelihood for prolongation of life and return to an active life;(4) No active infection at the time of the procedure;(5) No general medical contraindication for the procedure and anesthesia;(6) Informed consent shall be obtained from the patient or the patient's representative; and(7) Age restricted to fifty or under except when identical twin is histocompatible and then age limit may be fifty-five.Haw. Code R. § 17-1737-93
[Eff 08/01/94] (Auth: HRS § 346-14; 42 C.F.R. §431.10 ) (Imp: 42 C.F.R. §440.230; 42 U.S.C. §1396 b(i) )